Oncology and Kaposi sarcoma
Clinical research at Fondazione IRCCS Ca Granda Ospedale Maggiore Policlinico includes treatment-focused studies in advanced unresectable classic Kaposi sarcoma, with interest in patients whose disease has relapsed or remains refractory after prior standard therapy.
- Immunotherapy
- Targeted therapy
- Relapsed and refractory malignancy
The sponsor’s oncology activity reflects a focus on difficult-to-treat vascular neoplasms and post-treatment disease control.
Pediatric rheumatology
Another area of research interest is juvenile idiopathic arthritis, particularly in children in clinical remission on anti-TNF treatment, with attention to treatment continuity and therapeutic interchange between originator and biosimilar medicines.
- Juvenile idiopathic arthritis
- Biologic therapy
- Biosimilars
This work sits within pediatric inflammatory disease management and the evaluation of long-term tumor necrosis factor inhibition.
Child and adolescent psychiatry
The sponsor is also involved in studies addressing substance-induced psychosis and cannabis use disorder in juvenile patients, with clinical interest in psychiatric stabilization alongside ongoing antipsychotic treatment.
- Substance-induced psychosis
- Cannabis use disorder
- Antipsychotic treatment
These trials place emphasis on youth mental health, relapse-related symptoms, and adjunctive approaches in psychiatric care.
Cannabinoid-based therapy
Within psychiatric research, the sponsor has a specific therapeutic interest in cannabidiol as an add-on treatment for adolescent patients, linking substance use management with psychotic disorders in a controlled clinical setting.
- Cannabidiol
- Add-on therapy
- Adolescent psychiatry
This area connects psychopharmacology with the management of comorbid substance-related and psychotic symptoms.
